RNA-mediated Toxicity in Neurodegeneration

Some neurodegenerative disorders are believed to be due to RNA-induced cellular toxicity caused by the expansion of nucleotide-repeat sequences in DNA. Discover the latest research on RNA-mediated toxicity in neurodegeneration here.

January 14, 2022

AAV9/MFSD8 gene therapy is effective in preclinical models of neuronal ceroid lipofuscinosis type 7 disease.

The Journal of Clinical Investigation
Xin ChenSteven J Gray
January 13, 2022

Mesenchymal stem cell secretome protects against oxidative stress-induced ocular blast visual pathologies.

Experimental Eye Research
Kumar Abhiram JhaRajashekhar Gangaraju
January 12, 2022
Open Access

A molecular brake that modulates spliceosome pausing at detained introns contributes to neurodegeneration

BioRxiv : the Preprint Server for Biology
Yichang Jia
January 12, 2022
Open Access

Thymosin β4 Is an Endogenous Iron Chelator and Molecular Switcher of Ferroptosis.

International Journal of Molecular Sciences
Joanna I LachowiczPierpaolo Coni
January 12, 2022
Open Access

LRRK2 at Striatal Synapses: Cell-Type Specificity and Mechanistic Insights.

Patrick D SkeltonLoukia Parisiadou
January 11, 2022
Open Access

Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer's Disease.

Frontiers in Pharmacology
Giuseppe CarusoFilippo Caraci
January 11, 2022

Elevated granulocyte-colony stimulating factor and hematopoietic stem cell mobilization in Niemann-Pick Type C1 disease.

Journal of Lipid Research
Anouk G GroenenMarit Westerterp
January 7, 2022

Aminochrome Induces Neuroinflammation and Dopaminergic Neuronal Loss: A New Preclinical Model to Find Anti-inflammatory and Neuroprotective Drugs for Parkinson's Disease.

Cellular and Molecular Neurobiology
Fillipe Mendes De AraújoVictor Diógenes Amaral Silva
January 6, 2022

Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders.

Neurological Research and Practice
Sibylle JablonkaMichael Sendtner
January 6, 2022

Drosophila Unfolded Protein Response (UPR) Assays In Vitro and In Vivo.

Methods in Molecular Biology
Hidetaka KatowHyung Don Ryoo
January 3, 2022
Open Access

Selected Thiadiazine-Thione Derivatives Attenuate Neuroinflammation in Chronic Constriction Injury Induced Neuropathy.

Frontiers in Molecular Neuroscience
Sonia QureshiSami Ullah
December 31, 2021

Pathogenic tauR406W induced neurodegeneration and memory deficits rescued by HDAC6 null mutation in Drosophila melanogaster.

Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Arkajyoti Sarkar, Sahabudeen Sheik Mohideen
December 29, 2021

Posiphen Reduces the Levels of Huntingtin Protein through Translation Suppression.

Xu-Qiao ChenMaria L Maccecchini
December 27, 2021

Combined molecular, structural and memory data unravel the destructive effect of tramadol on hippocampus.

Neuroscience Letters
Aysan KhatmiAbbas Aliaghaei
December 27, 2021

Myelin-associated glycoprotein activation triggers glutamate uptake by oligodendrocytes in vitro and contributes to ameliorate glutamate-mediated toxicity in vivo.

Biochimica Et Biophysica Acta. Molecular Basis of Disease
Ana L VivinettoPablo H H Lopez
December 28, 2021

Neuronal ApoE4 stimulates C/EBPβ activation, promoting Alzheimer's disease pathology in a mouse model.

Progress in Neurobiology
Zhi-Hao WangKeqiang Ye
December 26, 2021

RAN proteins in neurodegenerative disease: Repeating themes and unifying therapeutic strategies.

Current Opinion in Neurobiology
Shu GuoLaura P W Ranum

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2022 Meta ULC. All rights reserved